Authorizes the use of opioid antagonists by public accommodations for opioid overdose prevention
Summary
Authorizes the use of opioid antagonists by persons or entities for opioid overdose prevention; defines "entity".
Bill status
signed
all 5 stages cleared
Introduction
May 2019
Committee Review
Mar 2020
Assembly Passage
Mar 2020
Senate Passage
Jul 2020
Signed into Law
Aug 2020
Introduced May 23, 2019
Signed Aug 24, 2020
Floor votes · Senate Jul 22, 2020 · Assembly Mar 2, 2020
How they voted
59–0
Passed
Total votes 59
Jul 22, 2020
D
Democratic39
100% Yea
R
Republican20
100% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
16
Key actions
4
Committee
5
Amendments
1
Aug 24, 2020
Signed into law
SIGNED CHAP.148
lower
Jul 22, 2020
Upper · Passed
PASSED SENATE
upper
Mar 2, 2020
Committee
REFERRED TO HEALTH
upper
Mar 2, 2020
Lower · Passed
PASSED ASSEMBLY
lower
Feb 4, 2020
Committee
REPORTED REFERRED TO CODES
lower
Jan 28, 2020
Lower · Passed
PRINT NUMBER 7812A
lower
Jan 28, 2020
Committee
AMEND (T) AND RECOMMIT TO HEALTH
lower
Jan 8, 2020
Committee
REFERRED TO HEALTH
lower
May 23, 2019
Committee
REFERRED TO HEALTH
lower
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about A 7812
Scope: NY
Hi! I can help you understand A 7812. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline